| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa9210a683781dd3ccadcb4c8584e6a8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate |
1991-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_876a98a12a226ae4d328eb1f2305f6b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b12e970b10c8b2c45eb82361b9b7b957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7abe98ee0bfde3c067221b4d6d12cc86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d932651c8c699be0593691fd2f0c1339
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c17300a552aa3a8fcd282cd682a12db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88e9c58eabeee0a2088ab1107931d3f2 |
| publicationDate |
1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5175264-A |
| titleOfInvention |
5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid |
| abstract |
This invention relates to 5-[4-[-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid (DISALAZINE) is provided as a new compound having anti-arthritic and immunomodulating properties. It can be produced via reaction of the diazonium salt of sulfadimidine reacted with salicylic acid and then acetylating the product anti-arthritic and immunomodulating properties. |
| priorityDate |
1991-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |